Evaluation of cholinesterase inhibitor treatment in patients with Alzheimer's disease using quantitative EEG

被引：0
|
作者：
Ekedahl, R [1 ]
Maria, EJ [1 ]
机构：
[1] Huddinge Univ Hosp, Karolinska Inst, Dept Neurotec, S-14186 Huddinge, Sweden
来源：
NEUROBIOLOGY OF AGING | 2002年 / 23卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
294
引用
收藏
页码：S77 / S77
页数：1
相关论文
共 50 条
  • [31] EEG synchronization and desynchronization pattern changes during cholinesterase inhibitors treatment in Alzheimer's disease
    Vysata, O.
    Pazdera, L.
    Prochazka, A.
    Kukal, J.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 141 - 141
  • [32] Metrifonate for Alzheimer's disease - Is the next cholinesterase inhibitor better?
    Knopman, DS
    NEUROLOGY, 1998, 50 (05) : 1203 - 1205
  • [33] Metrifonate for Alzheimer's disease: Is the next cholinesterase inhibitor better?
    Sandson, TA
    NEUROLOGY, 1999, 52 (03) : 675 - 676
  • [34] Persistence with cholinesterase inhibitor therapy in a population based cohort of patients with Alzheimer's disease
    Amuah, Joseph E.
    Hogan, David B.
    Eliasziw, Misha
    Supina, Alison
    Beck, Patricia
    Downey, Winanne
    Maxwell, Colleen J.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2010, 19 (07) : 670 - 679
  • [35] Cholinesterase inhibitor affects the amyloid precursor protein isoforms in patients with Alzheimer's disease
    Liu, HC
    Chi, CW
    Ko, SY
    Wang, HC
    Hong, CJ
    Lin, KN
    Wang, PN
    Liu, TY
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2005, 19 (5-6) : 345 - 348
  • [36] Pharmacokinetic-pharmacodynamic modeling of rivastigmine, a cholinesterase inhibitor, in patients with Alzheimer's disease
    Gobburu, JVS
    Tammara, V
    Lesko, L
    Jhee, SS
    Sramek, JJ
    Cutler, NR
    Yuan, RH
    JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 41 (10): : 1082 - 1090
  • [37] FDA approves new cholinesterase inhibitor for Alzheimer's disease
    不详
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2000, 57 (11) : 1026 - +
  • [38] Cholinesterase inhibitor therapies and neuropsychiatric manifestations of Alzheimer's disease
    Wynn, ZJ
    Cummings, JL
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2004, 17 (1-2) : 100 - 108
  • [39] Neuropsychological Evaluation and Quantitative EEG in Patients with Frontotemporal Dementia, Alzheimer's Disease, and Mild Cognitive Impairment
    Tomasello, Letteria
    Carlucci, Leonardo
    Lagana, Angelina
    Galletta, Santi
    Marinelli, Chiara Valeria
    Raffaele, Massimo
    Zoccolotti, Pierluigi
    BRAIN SCIENCES, 2023, 13 (06)
  • [40] Long-term tetrahydroaminoacridine treatment and quantitative EEG in Alzheimer's disease
    Kogan, E. A.
    Verchovsky, R. G.
    Neufeld, M. Y.
    Klimovitsky, S. Sh.
    Treves, T. A.
    Korczyn, A. D.
    JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 2007, (72): : 203 - 206
12345